<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
	<div class="test-story-main">
		<tabset>
			<tab heading="FULL"  vertical="false">
				<div class="panel-body">
					<div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The nurse documents administration for the inactivated influenza vaccine from a VFC source:&nbsp;</p><p style="margin-left: 20px;">- Is alerted that the patient is not eligible for VFC.</p><p style="margin-left: 20px;">- Orders a different non-VFC lot of inactivated influenza vaccine.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Order is placed for inactivated influenza vaccine.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The user is notified of vaccine dose ineligibility.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Notify of Vaccine Dose Ineligibility:&nbsp;</strong>The EHR or other clinical software system provides a method for alerting a provider if a vaccine is selected for a patient who is not eligible for the inventory item selected.</p><p><strong>Data Quality Checks:</strong> Integrate additional data quality checks into IIP Testing and Recognition to improve data quality and reduce rejections.</p><p>&nbsp;Note: The EHR or other clinical software system prevents specific data issues which would potentially result in IIS errors as defined by the AIRA Error Codes. This supports reducing data quality issues that could trigger the following AIRA-defined Error Codes:</p><p>&nbsp; - &nbsp;2013: Indicates that the funding source code in an OBX segment conflicts with other data in the message (eligibility, age etc).</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The provider documents a VFC lot to be administered in the EHR. Once notified that the patient is not eligible for the VFC, then a non-VFC lot is selected. The coded values are not expected to be displayed to the user, but it is expected that the value selected has the identified meaning, and it is expected that the system will use the coded value when the attribute is conveyed in later transactions:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td width="208">Entered BY<br></td><td width="266">Sandra Molina<br></td></tr><tr><td width="208">Ordering Provider<br></td><td width="266">Frank Smith<br></td></tr><tr><td width="208">Entering Organization<br></td><td width="266">Shoreline Pediatrics<br></td></tr><tr><td width="208">Vaccine Event information source<br></td><td width="266">New immunization record (NIP001 00)<br></td></tr><tr><td width="208">Value/Text for Vaccine Type<br></td><td width="266">Influenza, injectable,quadrivalent, preservative free, pediatric (CVX 161), FLUZONE QUADRIVALENT (NDC 49281-0520-00)<br></td></tr><tr><td width="208">Date/Time of Start of Administration<br></td><td width="266">Current Date<br></td></tr><tr><td width="208">Vaccine Administered<br></td><td width="266">Influenza, injectable,quadrivalent, preservative free, pediatric (CVX 161), FLUZONE QUADRIVALENT (NDC 49281-0520-00)<br></td></tr><tr><td width="208">Vaccine 2-D Data Matrix<br></td><td width="266"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 99px; height: 104.28px;"><br></td></tr><tr><td width="208">VFC lot (not administered)<br></td><td width="266">D8043IN8422<br></td></tr><tr><td width="208">Substance Expiration Date<br></td><td width="266">12/31/2021<br></td></tr><tr><td width="208">Substance Manufacturer Name<br></td><td width="266">Sanofi Pasteur (MVX PMC)<br></td></tr><tr><td width="208">Alert<br></td><td width="266">Patient is not VFC Eligible<br></td></tr><tr><td width="208">Funding Source<br></td><td width="266">Private<br></td></tr></tbody></table><p><br></p><p>The Provider selects a non-VFC Lot:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td valign="top" width="186">Vaccine Lot # (administered):<br></td><td valign="top" width="114">D8043IN8855<br></td></tr><tr><td valign="top" width="186">Vaccine Expiration Date:<br></td><td valign="top" width="114">12/31/2021<br></td></tr></tbody></table></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>The full vaccination details are provided here to facilitate the documentation constraints and/or screens that may be required by the vendor in order to attempt to document the data of interest, but these are not verified until the next step. Only those attributes specified that are anticipated to result in data quality alerts are required for this step.</p><p>&nbsp;Administration for the non-VFC dose of this vaccine is completed in the next step.</p></td></tr></table></div><br/>
				</div>
			</tab>
			<tab heading="Description" vertical="false"><div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The nurse documents administration for the inactivated influenza vaccine from a VFC source:&nbsp;</p><p style="margin-left: 20px;">- Is alerted that the patient is not eligible for VFC.</p><p style="margin-left: 20px;">- Orders a different non-VFC lot of inactivated influenza vaccine.</p></td></tr></table></div></tab><tab heading="Comments" vertical="false"><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div></tab><tab heading="Pre-condition" vertical="false"><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Order is placed for inactivated influenza vaccine.</p></td></tr></table></div></tab><tab heading="Post-Condition" vertical="false"><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The user is notified of vaccine dose ineligibility.</p></td></tr></table></div></tab><tab heading="Test Objectives" vertical="false"><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Notify of Vaccine Dose Ineligibility:&nbsp;</strong>The EHR or other clinical software system provides a method for alerting a provider if a vaccine is selected for a patient who is not eligible for the inventory item selected.</p><p><strong>Data Quality Checks:</strong> Integrate additional data quality checks into IIP Testing and Recognition to improve data quality and reduce rejections.</p><p>&nbsp;Note: The EHR or other clinical software system prevents specific data issues which would potentially result in IIS errors as defined by the AIRA Error Codes. This supports reducing data quality issues that could trigger the following AIRA-defined Error Codes:</p><p>&nbsp; - &nbsp;2013: Indicates that the funding source code in an OBX segment conflicts with other data in the message (eligibility, age etc).</p></td></tr></table></div></tab><tab heading="Evaluation Criteria" vertical="false"><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The provider documents a VFC lot to be administered in the EHR. Once notified that the patient is not eligible for the VFC, then a non-VFC lot is selected. The coded values are not expected to be displayed to the user, but it is expected that the value selected has the identified meaning, and it is expected that the system will use the coded value when the attribute is conveyed in later transactions:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td width="208">Entered BY<br></td><td width="266">Sandra Molina<br></td></tr><tr><td width="208">Ordering Provider<br></td><td width="266">Frank Smith<br></td></tr><tr><td width="208">Entering Organization<br></td><td width="266">Shoreline Pediatrics<br></td></tr><tr><td width="208">Vaccine Event information source<br></td><td width="266">New immunization record (NIP001 00)<br></td></tr><tr><td width="208">Value/Text for Vaccine Type<br></td><td width="266">Influenza, injectable,quadrivalent, preservative free, pediatric (CVX 161), FLUZONE QUADRIVALENT (NDC 49281-0520-00)<br></td></tr><tr><td width="208">Date/Time of Start of Administration<br></td><td width="266">Current Date<br></td></tr><tr><td width="208">Vaccine Administered<br></td><td width="266">Influenza, injectable,quadrivalent, preservative free, pediatric (CVX 161), FLUZONE QUADRIVALENT (NDC 49281-0520-00)<br></td></tr><tr><td width="208">Vaccine 2-D Data Matrix<br></td><td width="266"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 99px; height: 104.28px;"><br></td></tr><tr><td width="208">VFC lot (not administered)<br></td><td width="266">D8043IN8422<br></td></tr><tr><td width="208">Substance Expiration Date<br></td><td width="266">12/31/2021<br></td></tr><tr><td width="208">Substance Manufacturer Name<br></td><td width="266">Sanofi Pasteur (MVX PMC)<br></td></tr><tr><td width="208">Alert<br></td><td width="266">Patient is not VFC Eligible<br></td></tr><tr><td width="208">Funding Source<br></td><td width="266">Private<br></td></tr></tbody></table><p><br></p><p>The Provider selects a non-VFC Lot:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td valign="top" width="186">Vaccine Lot # (administered):<br></td><td valign="top" width="114">D8043IN8855<br></td></tr><tr><td valign="top" width="186">Vaccine Expiration Date:<br></td><td valign="top" width="114">12/31/2021<br></td></tr></tbody></table></td></tr></table></div></tab><tab heading="Notes" vertical="false"><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>The full vaccination details are provided here to facilitate the documentation constraints and/or screens that may be required by the vendor in order to attempt to document the data of interest, but these are not verified until the next step. Only those attributes specified that are anticipated to result in data quality alerts are required for this step.</p><p>&nbsp;Administration for the non-VFC dose of this vaccine is completed in the next step.</p></td></tr></table></div></tab>
		</tabset>
	</div>
</fieldset>